On May 1, 2020 Cellular Biomedicine Group Inc. (NASDAQ: CBMG) ("CBMG" or the "Company"), a biopharmaceutical firm engaged in the drug development of immunotherapies for cancer and stem cell therapies for degenerative diseases, reported that it will release its financial results for the first quarter ended March 31, 2020 after the market closes on Wednesday, May 6, 2020 (Press release, Cellular Biomedicine Group, MAY 1, 2020, View Source [SID1234556922]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
The Company will host a conference call and webcast with the investment community on Wednesday, May 6th at 5:00 p.m. Eastern Time, featuring remarks by Tony Liu, CEO, CFO and Executive Director of CBMG.
What:
Cellular Biomedicine Group First Quarter 2020 Results Conference Call
Date:
Wednesday, May 6, 2020
Time:
5:00 p.m. Eastern Time
Live Call:
Toll-Free: +1-833-423-0438
International: +1-918-922-6623
China: +86 800-870-0169 or +86 400-682-8609
Conference ID: 7690079
Webcast:
Replay:
Toll-Free: (855) 859-2056
International: (404) 537-3406
Conference ID: 7690079
(Available approximately two hours after the completion of the live call until 8:00 p.m. ET on May 20, 2020)